'Most Controversial Issue' in Early Breast Cancer Treatment

In an online poll over use of chemotherapy for premenopausal patients with early breast cancer, votes were split without consensus; debate on this issue continues.

Related Keywords

Germany ,Texas ,United States ,Dana Farber Cancer Institute ,Massachusetts ,Rhode Island ,Boston ,Italy ,Austria ,New Haven ,Connecticut ,Vienna ,Wien ,Dallas ,Reggio Emilia ,Emilia Romagna ,Susang Komen ,Haroldj Burstein ,Eric Winer ,Matteo Lambertini ,Stephaniel Graff ,Michael Gnant ,Kim Sabelko ,Paolo Tarantino ,Twitter ,Yale Cancer Center ,Journal Of The National Cancer Institute ,Centre Of Hematology ,University Of Modena ,Oncotype Dx Genomic Health ,Lifespan Cancer Institute ,University Of Vienna ,San Antonio Breast Cancer Symposium ,Medscape Medical ,Genomic Health ,Medical University ,Sibylle Loibl ,National Cancer Institute ,Angela Toss ,Medscape Medical News ,Policlinico San Martino ,Medscapemedical News ,Breast Cancer ,Alignant Breast Neoplasm ,Chemotherapy ,Cancer ,Alignant Neoplasia ,Arcinoma ,Metastasis ,Adjuvant Chemotherapy ,Endocrine Therapy ,Hormone Therapy ,Her2 Negative Breast Cancer ,Her2 Breast Cancer ,Tamoxifen ,Elective Estrogen Receptor Modulator Serm ,Amenorrhea ,Clinical Research ,Clinical Trials ,Linical Studies ,Healthcare And Medical Technology ,Ealth And Medical Tech ,Health And ,